Rates of both ischemic and hemorrhagic strokes in systemic lupus erythematosus (SLE) are affected by the racial…
Ashraf Malhas, PhD
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ashraf Malhas, PhD
Biologic treatments for lupus and other autoimmune diseases are safe for women who are pregnant, and do not have a…
Researchers identified a new player involved in the development of lupus nephritis, providing potentially new therapeutic intervention points. The protein, iRhom2, is…
Mixed connective tissue disease (MCTD), a chronic disorder that has overlapping features of two or more systemic rheumatic disorders, is…
The higher the body mass index, the higher the level of fatigue a lupus patient is likely to experience, Illinois…
SLE Patients with Pulmonary Arterial Hypertension Have ‘Relatively Good’ Survival Rates, Study Shows
A retrospective study shows that 83.9 percent of patients suffering from systemic lupus erythematosus (SLE) and pulmonary arterial hypertension survive at least…
Abnormal levels of microRNA in the blood of lupus nephritis patients could help doctors diagnose the kidney disorder and scientists…
Certain vitamin D receptor (VDR) variants are associated with systemic lupus erythematosus (SLE) and contribute to the development of lupus nephritis,…
Factors that might be predictive of different responses and outcomes in systemic lupus erythematosus (SLE) patients who are treated with…
Results from a 24-week Phase 2b study show that atacicept treatment is safe and reduces disease activity and severe flare…